Accepted for/Published in: JMIR Research Protocols
Date Submitted: Jun 1, 2023
Date Accepted: Oct 14, 2023
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Using mobile phone technology to prevent HIV and related Youth Health problems: Sexual health, Mental health, and Substance use in southwest Uganda (Youth Health SMS): a pilot, randomized controlled trial
ABSTRACT
Background:
Sub-Saharan Africa has the highest HIV incidence and prevalence in the world, with adolescents and young adults (AYA) at greatest risk. Despite availability of effective combination prevention tools, including recent availability of pre-exposure prophylaxis (PrEP), HIV incidence for AYA in Uganda remains high and PrEP use remains low. Mental health and substance use (i.e., behavioral health) play a role in sexual risk behavior and decision-making, contributing to an increase in risk for acquiring HIV. Further, in part due to lack of access to information and services that are related to mobility, uptake of antiretroviral therapy among AYA in Uganda living with HIV is considerably lower than in adults. Interventions to address multiple HIV risk factors, including sexual and mental health and problematic substance use, are crucial to ending the HIV epidemic, yet few such interventions currently exist that address health disparities and comorbidities among AYA in sub-Saharan Africa
Objective:
This study will evaluate the acceptability and feasibility of Kirabo, a text message intervention informed by the Information, Motivation, and Behavior (IMB) model and that will be disseminated through secondary schools. In addition, we will gather preliminary estimates of Kirabo’s effectiveness at increasing HIV testing and linkage to mental health counselors.
Methods:
We identified Mobile 4 Reproductive Health (m4RH) as a promising candidate for adaptation using the ADAPT-ITT framework. M4RH is an evidence-based automated two-way text messaging and interactive voice response (IVR) platform that offers SRH information and links users to HIV clinics in East Africa. We will then conduct a 2-arm, randomized controlled trial (RCT) in Masaka, Uganda. Participants (N=200) will be recruited from local schools. Baseline sociodemographic characteristics, HIV test history and behavioral health symptoms will be assessed. Twice per week during the intervention, Kirabo will send enrolled adolescents a text message focused on HIV testing, PrEP and behavioral health. Texting with the platform is free in Uganda. We will evaluate acceptability and feasibility using surveys, interviews, and mobile phone data. Preliminary efficacy of Kirabo to increase HIV testing and link with mental health counselors will be evaluated immediately post intervention and 3-month follow up. We also will assess the intervention’s impact on self-efficacy to: HIV test, uptake PrEP, and link with a mental health counselor.
Results:
Intervention adaptation began in 2019. A pre-test was conducted in 2021. The RCT, including usability and feasibility assessments, and effectiveness measurement, is anticipated to commence in June 2023.
Conclusions:
The Kirabo intervention includes local HIV clinic information, PrEP information and behavioral health screening, with referral as needed. The intervention may offer an additional tool to assist in efforts to end the epidemic by targeting health disparities and comorbidities among adolescents in Uganda. Results will inform a larger trial to measure intervention effectiveness. Clinical Trial: https://clinicaltrials.gov/ct2/show/NCT05130151
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.